Catalyst Wire Dossier Catalyst Wire Dossier

Parainfluenza Type 3 vaccine (recombinant live attenuated)

recombinant live attenuated Parainfluenza Type 3 virus vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Parainfluenza Type 3 vaccine (recombinant live attenuated), covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children [Phase 1]

See pricing